E-LIB Suche - Ergebnisse für: Peppercorn, Amanda

1

Inhibition of Receptor-Interacting Protein Kinase 1 in Chro..:

Ludbrook, Valerie J. ; Budd, David C. ; Thorn, Katie...
Dermatology and Therapy. 14 (2024) 2 - p. 489-504 , 2024

2

Effect of Bamlanivimab as Monotherapy or in Combination wit..:

Nichols, Russell M. ; Macpherson, Lisa ; Patel, Dipak R...
Infectious Diseases and Therapy. 13 (2024) 2 - p. 401-411 , 2024

Link: https://doi.org/10.1007/..

3

Resistance analysis in the phase III COMET-TAIL study: trea..:

Agostini, Maria L ; Schnell, Gretja ; Iulio, Julia di...
Future Virology. , 2024

Link: https://doi.org/10.1080/..

4

Population pharmacokinetics and exposure‐response analysis ..:

Sager, Jennifer E. ; El‐Zailik, Asma ; Passarell, Julie...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 6 - p. 853-864 , 2023

Link: https://doi.org/10.1002/..

5

Resistance Analysis Following Sotrovimab Treatment in Parti..:

Subramanian, Sambhavi ; Schnell, Gretja ; Iulio, Julia di...
Future Virology. 18 (2023) 15 - p. 975-990 , 2023

Link: https://doi.org/10.2217/..

6

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibo..:

Shapiro, Adrienne E ; Sarkis, Elias ; Acloque, Jude...
Open Forum Infectious Diseases. 10 (2023) 8 - p. , 2023

Link: https://doi.org/10.1093/..

7

304. Viral resistance analysis in the COMET-PEAK study: sot..:

Yates, Phillip J ; Moore, Jennifer ; Han, Jennifer...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

8

1154. Safety, Tolerability, and Viral Pharmacodynamics of t..:

Gupta, Anil K ; Perez-Rodríguez, Maria Teresa ; Gonzalez-Rojas, Yaneicy...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

9

Antibody therapy reverses biological signatures of COVID-19..:

Maher, M. Cyrus ; Soriaga, Leah B. ; Gupta, Anil...
Cell Reports Medicine. 3 (2022) 8 - p. 100721 , 2022

Link: https://doi.org/10.1016/..

10

1150. Resistance Analysis in the COMET-TAIL Study: Particip..:

Agostini, Maria L ; Schnell, Gretja ; di Iulio, Julia...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

11

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing ..:

Gupta, Anil K ; Rojas, Yaneicy Gonzalez ; Juarez, Erick...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S353-S354 , 2021

Link: https://doi.org/10.1093/..

12

Zanamivir aqueous solution in severe influenza: A global Co..:

Wang‐Jairaj, Jie ; Miller, Irene ; Joshi, Aditya...
Influenza and Other Respiratory Viruses. 16 (2021) 3 - p. 542-551 , 2021

Link: https://doi.org/10.1111/..

13

Population Pharmacokinetic/Pharmacodynamic Analysis of Intr..:

Zuo, Peiying ; Collins, Jon ; Okour, Malek...
Clinical and Translational Science. 13 (2019) 1 - p. 157-168 , 2019

Link: https://doi.org/10.1111/..

14

The safety, tolerability, and pharmacokinetic profile of GS..:

Johnson, Mark ; Jewell, Roxanne C. ; Peppercorn, Amanda...
Pharmacology Research & Perspectives. 6 (2018) 4 - p. , 2018

Link: https://doi.org/10.1002/..

15

Safety, Tolerability and Pharmacokinetics (PK) of Intraveno..:

Blumer, Jeffrey ; Bradley, John S. ; Romero, Jose R....
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..